Zhejiang U | College of Pharmaceutical Sciences | 中文版
     
     
Feng ZHU - IDRC - Chongqing University
ABOUT THE PRINCIPAL INVESTIGATOR

Dr. Feng ZHU

Distinguished Professor, Tenured Professor, Zhejiang University, China

Highly Cited Researcher, Clarivate, United States 

Web of Science h-index: 60 ;   Scopus h-index: 60 ;   Google Scholar h-index: 59

zhufeng(at)zju.edu.cn (primary), prof.zhufeng(at)gmail.com; +86-571-88208444

PERSONAL DETAILS
Research Interests: Medicinal Chemistry, Drug Design, Target Discovery, Bioinformatics and System Biology

Based on the artificial intelligence and OMIC (proteomics and metabolomics) technologies, we conduct systematical exploration on the druggability and system profile of therapeutic drug targets, develop novel methods and online tools for target discovery, and further study the mechanism underlying the interaction between drugs and their corresponding targets.

  Academic Appointments and Educational Qualifications
  Honors and Awards
    Representative Honors & Awards

  • Leading Talent of the National High-Level Talent Special Support Plan of China (2020)
  • Honorable Professor of the Youth International Recruitment Program of China (2014)
  • Laureate of the Highly Cited Researcher of Clarivate (2023)
  • Leading Talent of the Science & Technology Nova Program of Chinese MOST (2019)
  • Corresponding Author of the Publications of Top-100 World-wide Impact of Chinese MOST (2021)
  • Laureate of the Fund for Distinguished Young Scholars of Zhejiang Province (2021)
  • Honorable Professor of the High-level Talent Support Plan of Zhejiang Province (2018)
  • Laureate of the Grand Prize in Natural Science of Bioinformatics Society of Zhejiang Province (Ranked the First,  2023)
  • Laureate of the 100,000 Top-scientists of Global Author ID Database (from 2021 to 2023)
  • Laureate of the 100,000 Top-scientists of Stanford University Science-wide Author Database (from 2021 to 2023)
  • Laureate of the Best Biology and Biochemistry Scientists of Global Academic Sites Research.com (from 2022 to 2023)
  • Laureate of the Top-10 Annual Scientific Advances in Bioinformatics in China of Elsevier Publication Group (2023)
  • Laureate of the 13th Top 10 Outstanding Students of Zhejiang University (Fengcheng Li, 2024)
  • Other Honors & Awards

  • Key Innovative Team Member of the Science & Technology Nova Program of Chinese MOST (2019)
  • Laureate of the First Class Science & Technology Award of Chongqing Province (Ranked the Fourth,  2019)
  • Laureate of the Leading Scholar in Social Practice of JiuSan Society (2021)
  • Supervisor of the Outstanding Doctor Postgraduate of Zhejiang Province (Fengcheng Li, 2023)
  • Supervisor of the Outstanding Doctor Postgraduate of Zhejiang Province (Jianbo Fu, 2021)
  • Supervisor of the Outstanding Master Postgraduate of Zhejiang Province (Jiajun Hong, 2020)
  • Laureate of the Excellent Teaching Case for Postgraduates of Zhejiang Province (2024)
  • Laureate of the Excellent Practical Achievement for Postgraduates of Zhejiang Province (2024)
  • Supervisor of the Third Class Challenge Cup Award of Zhejiang Province (2021)
  • Laureate of the Top Cited Paper Award of Wiley Publication Group (2020)
  • Laureate of the First Class Shihuayu Teaching Scholarship of Zhejiang University (2021)
  • Laureate of the School-level Teaching Scholarship (2023)
  • Supervisor of the Jiangzhi Biomedical Award of Zhejiang University (2020)
  • Supervisor of the Second Class Challenge Cup Award of Zhejiang University (2021)
  • Laureate of the Third Class Tanglixin Teaching Scholarship of Chongqing University (2014)
  • Laureate of the Top-10 Annual Scientific Advances of College of Pharmaceutical Sciences in Zhejiang University (2022,  2023)
  • Laureate of the Annual Outstanding Professor of College of Pharmaceutical Sciences in Zhejiang University (2020)
  • Laureate of the Annual Outstanding Professor of College of Pharmaceutical Sciences in Zhejiang University (2019)
  Educational Reform Projects (PI: Principal Investigator; PP: Project Participant)
  • 2022.10 - (PI, 省部级): IECC Foundation of the Ministry of Education of China (2022-AliC-4-32)
  • 2021.12 - (PI, 省部级): Textbook Construction in 13th Five-Year Plan of Zhejiang Province (2021-135-33)
  • 2021.01 - (PI, 学校级): Postgraduate Education Reform Foundation of China (zyjyjx-grazju-49)
  • 2020.06 - (PI, 学校级): Undergraduate Education Reform Foundation of China (068-484607)
  • 2020.09 - (PI, 学校级): Postgraduate Education Reform Foundation of Zhejiang University (1913039)
  Research Grants (PI: Principal Investigator; PP: Project Participant)
    Project(s) on Going

  • 2024.01 - (PI, 国家级): National Natural Science Foundation General Program of China (82373790)
  • 2023.01 - (PI, 国家级): National Natural Science Foundation Key Program of China (22220102001)
  • 2021.01 - (PI, 省部级): Fund for Distinguished Young Scholars of Zhejiang Province (LR21H300001)
  • 2020.10 - (PI, 国家级): National Leading Talent Special Support Plan of China (CWR-L-ZJU2020-ZF)
  • 2020.01 - (PI, 国家级): National Natural Science Foundation Collaboration Program of China (U1909208)
  • Project(s) Completed

  • 2014.06 - (PI, 国家级): Youth International Recruitment Program of China (IRPC-Y-CQU2014-ZF)
  • 2016.08 - (PI, 国家级): National Key Research and Development Program of China (2016YFC0902200)
  • 2018.09 - (PI, 国家级): National Key Research and Development Program of China (2018YFC0910500)
  • 2019.01 - (PI, 国家级): National Natural Science Foundation General Program of China (81872798)
  • 2013.01 - (PI, 国家级): National Natural Science Foundation Youth Program of China (81202459)
  • 2015.12 - (PI, 省部级): Special Fund for Chemical Drug Discovery of Chongqing Province (cstc2015zdcy-ztzx120003)
  • 2020.01 - (PI, 省部级): Key Research and Development Program of Zhejiang Province (2020C03010)
  • 2021.05 - (PI, 省部级): Research Fund for Injury Prevention of Zhejiang Province (181201*194232101)
  • 2012.09 - (PI, 省部级): Natural Science Foundation General Program of Chongqing Province (cstc2012jjA10116)
  • 2021.02 - (PI, 学校级): Fund for Future Digital Healthcare of Alibaba-ZJU Collaboration (ALIZJU202101)
  • 2017.07 - (PI, 学校级): Hundreds-Talents Program of Zhejiang University (ZJU2017070, evaluated as "Excellent")
  • 2012.07 - (PI, 学校级): Hundreds-Talents Program of Chongqing University (0903005203176, evaluated as "Excellent")
  • 2014.06 - (PI, 学校级): Major Fundation for Chongqing University (CDJZR14 46 88 01, evaluated as "Excellent")
  • 2013.01 - (PI, 学校级): Key Fundation for Chongqing University (CQDXWL-2012-Z003, evaluated as "Excellent")
  • 2018.01 - (PI, 学校级): Youth Research Innovation Grant of Zhejiang University (2018QNA7023)
  Published Key Textbooks ( front cover of the book)
  • 2023.01 (Undergraduate Textbook) : "AI in Medicine"    ISBN 978-7-308-23491-7, Zhejiang University Press
  • The Unique Feature of This Book:
    • Key Textbook for the Universities of Zhejiang Province in the 14th Five-Year Plan

  • 2023.06 (Drug Discovery Book) : "Artificial Intelligence and Drug Design"    ISBN 978-7-122-42928-5, Chemical Industry Press
  • The Unique Feature of This Book:
    • Key Project Supported by Chinese National Publication Foundation (2023)

  • 2023.03 (Undergraduate Textbook) : "Drug Design"    ISBN 978-7-04-059211-5, Higher Education Press
  • The Unique Feature of This Book:
    • Key Textbook for the Ministry of Industry and Information Technology of China
    • Key Textbook for the Medical Education of China in the 14th Five-Year Plan
    • Key Textbook for the National Education of China in the 11th Five-Year Plan

  Selected Core Publications (*corresponding author; published cover article; PDF version of paper)
  1. J. B. Fu, Y. Zhang, Y. X. Wang, H. N. Zhang, J. Liu, J. Tang, Q. X. Yang, H. C. Sun, W. Q. Qiu, Y. H. Ma, Z. R. Li, M. Y. Zheng, F. Zhu*. Optimization of metabolomic data processing using NOREVA. Nature Protocols (impact factor of the publication year: 17.021, 生物一区 TOP 期刊). 17(1): 129-151 (2022). PMID: 34952956.
  2. Featured Article: ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.26% in 2023.
    Media Coverage & News Report:

  3. L. Y. Zheng, S. Y. Shi, M. K. Lu, P. Fang, Z. Q. Pan, H. N. Zhang, Z. M. Zhou, H. Y. Zhang, M. J. Mou, S. J. Huang, L. Tao, W. Q. Xia, H. L. Li, Z. Y. Zeng, S. Zhang, Y. Z. Chen, Z. R. Li*, F. Zhu*. AnnoPRO: a strategy for protein function annotation based on multi-scale protein representation and a hybrid deep learning of dual-path encoding. Genome Biology (impact factor of the publication year: 12.3, 生物一区 TOP 期刊). accepted: GBIO-D-23-00628 (2024). PMID: XXXXXXXX.
  4. Y. X. Wang, S. Zhang, F. C. Li, Y. Zhou, Y. Zhang, Z. W. Wang, R. Y. Zhang, J. Zhu, Y. X. Ren, Y. Tan, C. Qin, Y. H. Li, X. X. Li, Y. Z. Chen*, F. Zhu*. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Research (impact factor of the publication year: 16.971, 生物一区 TOP 期刊). 48(D1): 1031-1041 (2020). PMID: 31691823.
  5. Publication of World-wide Reputation: ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.12% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.13% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.15% in 2021.
    Media Coverage & News Report:

  6. Y. T. Zhang, Y. Zhou, Y. Zhou, X. Y. Yu, X. Y. Shen, Y. F. Hong, Y. X. Zhang, S. S. Wang, M. J. Mou, J. S. Zhang, L. Tao, J. Q. Gao, Y. Q. Qiu*, Y. Z. Chen*, F. Zhu*. TheMarker: a comprehensive database of therapeutic biomarkers. Nucleic Acids Research (当年影响因子: 14.9, 生物二区 TOP 期刊). 52(D1): 1450-1464 (2024). PMID: 37850638.
  7. 封面论文:
    • The Cover Article of Nucleic Acids Res 2024 52(D1), Download the Cover .

  8. F. C. Li, J. Y. Yin, M. K. Lu, M. J. Mou, Z. R. Li, Z. Y. Zeng, Y. Tan, S. S. Wang, X. Y. Chu, H. B. Dai, T. J. Hou, S. Zeng*, Y. Z. Chen*, F. Zhu*. DrugMAP: molecular atlas and pharma-information of all drugs. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(D1): 1288-1299 (2023). PMID: 36243961.
  9. Cover Article:
    • The Cover Article of Nucleic Acids Res 2023 51(D1), Download the Cover .
    Media Coverage & News Report:

  10. Y. Zhang, H. C. Sun, X. C. Lian, J. Tang, F. Zhu*. ANPELA: significantly enhanced quantification tool for cytometry-based single-cell proteomics. Advanced Science (impact factor of the publication year: 17.521, 工程技术一区 TOP 期刊). 10(15): e2207061 (2023). PMID: 36950745.
  11. Cover Article:

  12. Y. H. Li, X. X. Li, J. J. Hong, Y. X. Wang, J. B. Fu, H. Yang, C. Y. Yu, F. C. Li, J. Hu, W. W. Xue, Y. Y. Jiang, Y. Z. Chen*, F. Zhu*. Clinical trials, progression-speed differentiating features, and swiftness rule of the innovative targets of first-in-class drugs. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(2): 649-662 (2020). PMID: 30689717.
  13. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.36% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.49% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.09% in 2021.

  14. Q. X. Yang, B. Li, J. Tang, X. J. Cui, Y. X. Wang, X. F. Li, J. Hu, Y. Z. Chen, W. W. Xue, Y. Lou, Y. Q. Qiu*, F. Zhu*. Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(3): 1058-1068 (2020). PMID: 31157371.
  15. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.29% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.56% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.19% in 2021.

  Selected Important Publications (*corresponding author; published cover article; PDF version of paper)
  1. M. J. Mou, Z. Q. Pan, Z. M. Zhou, L. Y. Zheng, H. Y. Zhang, S. Y. Shi, F. C. Li, X. N. Sun, F. Zhu*. A transformer-based ensemble framework for the prediction of protein-protein interaction sites. Research (impact factor of the publication year: 11.016, 综合一区 TOP 期刊). 6: 0240 (2023). PMID: 37771850.
  2. Media Coverage & News Report:

  3. L. Y. Zheng, S. Y. Shi, M. K. Lu, P. Fang, Z. Q. Pan, H. N. Zhang, Z. M. Zhou, H. Y. Zhang, M. J. Mou, S. J. Huang, L. Tao, W. Q. Xia, H. L. Li, Z. Y. Zeng, S. Zhang, Y. Z. Chen, Z. R. Li*, F. Zhu*. AnnoPRO: a strategy for protein function annotation based on multi-scale protein representation and a hybrid deep learning of dual-path encoding. Genome Biology (impact factor of the publication year: 12.3, 生物一区 TOP 期刊). accepted: GBIO-D-23-00628 (2024). PMID: XXXXXXXX.
  4. Y. X. Wang, Z. Chen, Z. Q. Pan, S. J. Huang, J. Liu, W. Q. Xia, H. N. Zhang, M. Y. Zheng, H. L. Li, T. J. Hou, F. Zhu*. RNAincoder: a deep learning-based encoder for RNA and RNA-associated interaction. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(W1): 509-519 (2023). PMID: 37166951.
  5. Y. X. Wang, Z. Q. Pan, M. J. Mou, W. Q. Xia, H. N. Zhang, H. Y. Zhang, J. Liu, L. Y. Zheng, Y. C. Luo, H. Q. Zheng, X. Y. Yu, X. C. Lian, Z. Y. Zeng, Z. R. Li, B. Zhang, M. Y. Zheng, H. L. Li, T. J. Hou, F. Zhu*. A task-specific encoding algorithm for RNAs and RNA-associated interactions based on convolutional autoencoder. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). 51(21): e110 (2023). PMID: 37889083.
  6. Y. Zhou, Y. T. Zhang, D. H. Zhao, X. Y. Yu, X. Y. Shen, Y. Zhou, S. S. Wang, Y. Q. Qiu, Y. Z. Chen*, F. Zhu*. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). doi: 10.1093/nar/gkad751 (2024). PMID: PMID: 37713619.
  7. L. T. Shen, X. N. Sun, Z. Chen, Y. Guo, Z. Y. Shen, Y. Song, W. X. Xin, H. Y. Ding, X. Y. Ma, W. B. Xu, W. Y. Zhou, J. X. Che, L. L. Tan, L. S. Chen, S. Q. Chen, X. W. Dong*, L. Fang*, F. Zhu*. ADCdb: the database of antibody-drug conjugates. Nucleic Acids Research (当年影响因子: 19.160, 生物二区 TOP 期刊). accepted: NAR-02369-Data-E-2023 (2024). PMID: 37831118.
  8. Y. T. Zhang, Y. Zhou, Y. Zhou, X. Y. Yu, X. Y. Shen, Y. F. Hong, Y. X. Zhang, S. S. Wang, M. J. Mou, J. S. Zhang, L. Tao, J. Q. Gao, Y. Q. Qiu*, Y. Z. Chen*, F. Zhu*. TheMarker: a comprehensive database of therapeutic biomarkers. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02063-Data-E-2023 (2024). PMID: 37850638.
  9. X. C. Lian, Y. T. Zhang, Y. Zhou, X. N. Sun, S. J. Huang, H. B. Dai*, L. Y. Han*, F. Zhu*. SingPro: a knowledge base providing single-cell proteomic data. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02157-Data-E-2023 (2024). PMID: 37819028.
  10. J. Y. Yin, Z. Chen, N. X. You, F. C. Li, H. Y. Zhang, J. Xue, H. Ma, Q. W. Zhao, L. S. Yu*, S. Zeng*, F. Zhu*. VARIDT 3.0: the phenotypic and regulatory variability of drug transporter. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02109-Data-E-2023 (2024). PMID: 37819041.
  11. Y. Zhang, X. G. Liu, F. C. Li, J. Y. Yin, H. Yang, X. D. Li, X. Y. Liu, X. Chai, T. L. Niu, S. Zeng*, Q. Z. Jia*, F. Zhu*. INTEDE 2.0: the metabolic roadmap of drugs. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). NAR-02756-Data-E-2023 (2023). PMID: 37930837.
  12. Y. Zhang, H. C. Sun, W. Zhang, T. T. Fu, S. J. Huang, M. J. Mou, J. S. Zhang, J. Q. Gao, Y. C. Ge*, Q. X. Yang*, F. Zhu*. CellSTAR: a comprehensive resource for single-cell transcriptomic annotation. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02385-Data-E-2023 (2024). PMID: 37855686.
  13. Q. X. Yang, Y. X. Wang, Y. Zhang, F. C. Li, W. Q. Xia, Y. Zhou, Y. Q. Qiu, H. L. Li, F. Zhu*. NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data. Nucleic Acids Research (impact factor of the publication year: 16.971, 生物一区 TOP 期刊). 48(W1): 436-448 (2020). PMID: 32324219.
  14. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.87% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 1.60% in 2022.
    Media Coverage & News Report:

  15. X. N. Sun, Y. T. Zhang, H. Y. Li, Y. Zhou, S. Y. Shi, Z. Chen, X. He, H. Y. Zhang, F. C. Li, J. Y. Yin, M. J. Mou, Y. Z. Wang, Y. Q. Qiu, F. Zhu*. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(D1): 1263-1275 (2023). PMID: 36243960.
  16. Media Coverage & News Report:

  17. T. T. Fu, F. C. Li, Y. Zhang, J. Y. Yin, W. Q. Qiu, X. D. Li, X. G. Liu, W. W. Xin, C. Z. Wang, L. S. Yu, J. Q. Gao, Q. C. Zheng*, S. Zeng*, F. Zhu*. VARIDT 2.0: structural variability of drug transporter. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 50(D1): 1417-1431 (2022). PMID: 34747471.
  18. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 1.48% in 2023.
    Media Coverage & News Report:

  19. J. Y. Yin, F. C. Li, Y. Zhou, M. J. Mou, Y. J. Lu, K. L. Chen, J. Xue, Y. C. Luo, J. B. Fu, X. He, J. Q. Gao, S. Zeng*, L. S. Yu*, F. Zhu*. INTEDE: interactome of drug-metabolizing enzymes. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 49(D1): 1233-1243 (2021). PMID: 33045737.
  20. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 1.01% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.
    Media Coverage & News Report:

  21. B. Li, J. Tang, Q. X. Yang, S. Li, X. J. Cui, Y. H. Li, Y. Z. Chen, W. W. Xue, X. F. Li, F. Zhu*. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Research (impact factor of the publication year: 10.162, 生物一区 TOP 期刊). 45(W1): 162-170 (2017). PMID: 28525573.
  22. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.60% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.77% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.71% in 2021.
    • The Percentile in Subject Area shown in InCites™ was 0.75% in 2020.
    • The Percentile in Subject Area shown in InCites™ was 1.27% in 2019.
    • The Percentile in Subject Area shown in InCites™ was 2.98% in 2018.
    Highlights by Experts in Subject Area:
    • Introduced by OMICTOOLS as "provided valuable guidance to the selection of suitable algorithm in metabolomics".
    • Discussed in StackExchange as "works fine" and "corrections for batches without QC options".

  23. Y. H. Li, C. Y. Yu, X. X. Li, P. Zhang, J. Tang, Q. X. Yang, T. T. Fu, X. Y. Zhang, X. J. Cui, G. Tu, Y. Zhang, S. Li, F. Y. Yang, Q. Sun, C. Qin, X. Zeng, Z. Chen, Y. Z. Chen*, F. Zhu*. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Research (impact factor of the publication year: 11.561, 生物一区 TOP 期刊). 46(D1): 1121-1127 (2018). PMID: 29140520.
  24. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.28% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.21% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.15% in 2021.
    • The Percentile in Subject Area shown in InCites™ was 0.14% in 2020.
    • The Percentile in Subject Area shown in InCites™ was 0.16% in 2019.
    Highlights by Experts in Subject Area:
    • Introduced by OMICTOOLS as "useful for facilitating patient focused research, discovery and clinical investigations of the targeted therapeutics".

  25. J. Y. Yin, W. Sun, F. C. Li, J. J. Hong, X. X. Li, Y. Zhou, Y. J. Lu, M. Z. Liu, X. Zhang, N. Chen, X. P. Jin, J. Xue, S. Zeng*, L. S. Yu*, F. Zhu*. VARIDT 1.0: variability of drug transporter database. Nucleic Acids Research (impact factor of the publication year: 16.971, 生物一区 TOP 期刊). 48(D1): 1042-1050 (2020). PMID: 31495872.
  26. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.81% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.96% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.33% in 2021.
    Media Coverage & News Report:

  27. K. Amahong, W. Zhang, Y. Zhou, S. Zhang, J. Y. Yin, F. C. Li, H. Q. Xu, T. C, Yan, Z. X. Yue, Y. H. Liu, T. J. Hou, Y. Q. Qiu, L. Tao*, L. Y. Han*, F. Zhu*. CovInter: interaction data between coronavirus RNAs and host proteins. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(D1): 546-556 (2023). PMID: 36200814.
  28. Media Coverage & News Report:

  29. M. K. Lu, J. Y. Yin, Q. Zhu, G. L. Lin, M. J. Mou, F. Y. Liu, Z. Q. Pan, N. X. You, X. C. Lian, F. C. Li, H. N. Zhang, L. Y. Zheng, W. Zhang, H. Y. Zhang, Z. H. Shen, Z. Gu, H. L. Li*, F. Zhu*. Artificial intelligence in pharmaceutical sciences. Engineering (impact factor of the publication year: 12.834, 工程技术一区 TOP 期刊). doi: 10.1016/j.eng.2023.01.014 (2023). PMID: XXXXXXXX.
  30. L. Y. Zheng, S. Y. Shi, X. N. Sun, M. K. Lu, Y. Liao, S. S. Zhu, H. N. Zhang, Z. Q. Pan, P. Fang, Z. Y. Zeng, H. L. Li, Z. R. Li*, W. W. Xue*, F. Zhu*. MoDAFold: a strategy for predicting the structure of missense mutant protein based on AlphaFold2 and molecular dynamics. Briefings in Bioinformatics (impact factor of the publication year: 9.5, 生物二区 TOP 期刊). doi: accepted: BIB-23-2257 (2024). PMID: XXXXXXXX.
  31. H. N. Zhang, M. K. Lu, G. L. Lin, L. Y. Zheng, W. Zhang, Z. J. Xu, F. Zhu*. SoCube: an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物二区 TOP 期刊). 24(3): bbad104 (2023). PMID: 36941114.
  32. H. Y. Zhang, Y. X. Wang, Z. Q. Pan, X. N. Sun, M. J. Mou, B. Zhang, Z. R. Li, H. L. Li*, F. Zhu*. ncRNAInter: a novel strategy based on graph neural network to discover interactions between lncRNA and miRNA. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(6): bbac411 (2022). PMID: 36198065.
  33. J. J. Hong, Y. C. Luo, M. J. Mou, J. B. Fu, Y. Zhang, W. W. Xue, T. Xie, L. Tao*, Y. Lou*, F. Zhu*. Convolutional neural network-based annotation of bacterial type IV secretion system effectors with enhanced accuracy and reduced false discovery. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(5): 1825-1836 (2020). PMID: 31860715.
  34. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.73% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 1.18% in 2022.

  35. J. J. Hong, Y. C. Luo, Y. Zhang, J. B. Ying, W. W. Xue, T. Xie, L. Tao*, F. Zhu*. Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(4): 1437-1447 (2020). PMID: 31504150.
  36. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.58% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.94% in 2022.

  37. J. Tang, J. B. Fu, Y. X. Wang, B. Li, Y. H. Li, Q. X. Yang, X. J. Cui, J. J. Hong, X. F. Li, Y. Z. Chen, W. W. Xue, F. Zhu*. ANPELA: analysis and performance-assessment of the label-free quantification workflow for metaproteomic studies. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(2): 621-636 (2020). PMID: 30649171.
  38. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.30% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.20% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.05% in 2021.

  39. F. C. Li, Y. Zhou, Y. Zhang, J. Y. Yin, Y. Q. Qiu, J. Q. Gao, F. Zhu*. POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(2): bbac040 (2022). PMID: 35183059.
  40. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.06% in 2023.

  41. F. C. Li, J. Y. Yin, M. K. Lu, Q. X. Yang, Z. Y. Zeng, B. Zhang, Z. R. Li, Y. Q. Qiu, H. B. Dai, Y. Z. Chen*, F. Zhu*. ConSIG: consistent discovery of molecular signature from OMIC data. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(4): bbac253 (2022). PMID: 35758241
  42. Q. X. Yang, J. J. Hong, Y. Li, W. W. Xue, S. Li*, H. Yang*, F. Zhu*. A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(6): 2142-2152 (2020). PMID: 31776543.
  43. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 2.30% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 2.69% in 2022.

  44. S. Zhang, K. Amahong, C. Y. Zhang, F. C. Li, J. Q. Gao, Y. Q. Qiu*, F. Zhu*. RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(1): bbab397 (2022). PMID: 34585235.
  45. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.12% in 2023.

  46. S. Zhang, F. Zhu*. Comment on microRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs (impact factor of the publication year: 11.431, 医学二区 TOP 期刊). 81(14): 1691-1692 (2021). PMID: 34453690.
  47. Q. X. Yang, S. M. Chen, W. Y. Jiang, L. Mi, J. R. Liu, Y. Hu, X. L. Ji*, J. Wang*, F. Zhu*. MultiClassMetabo: superior classification model constructed using metabolic markers in multiclass metabolomics. Analytical Chemistry (impact factor of the publication year: 7.4, 化学一区 TOP 期刊). accepted: ac-2023-03212v (2024). PMID: XXXXXXXX.
  48. Q. X. Yang*, Y. G. Gong, F. Zhu*. Critical assessment of the biomarker discovery and classification methods for multiclass metabolomics. Analytical Chemistry (impact factor of the publication year: 8.008, 化学一区 TOP 期刊). 95(13): 5542-5552 (2023). PMID: 36944135.
  49. Y. X. Wang, F. C. Li, Y, Zhang, Y. Zhou, Y. Tan, Y. Z. Chen*, F. Zhu*. Databases for the targeted COVID-19 therapeutics. British Journal of Pharmacology (impact factor of the publication year: 7.730, 医学二区 TOP 期刊). 177(21): 4999-5001 (2020). PMID: 32845521.
  50. Q. X. Yang, Y. X. Wang, F. C. Li, S. Zhang, Y. C. Luo, Y. Li, J. Tang, B. Li, Y. Z. Chen, W. W. Xue, F. Zhu*. Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility. CNS Neuroscience & Therapeutics (impact factor of the publication year: 7.035, 医学一区 TOP 期刊). 25(9): 1054-1063 (2019). PMID: 31350824.
  51. Cover Article:
    • The Cover Article of CNS Neurosci Ther 2019 25(9), Download the Cover .

  52. Z. J. Han, W. W. Xue, L. Tao, F. Zhu*. Identification of novel immune-relevant drug target genes for alzheimer's disease by combining ontology inference with network analysis. CNS Neuroscience & Therapeutics (impact factor of the publication year: 7.035, 医学一区 TOP 期刊). 24(12): 1253-1263 (2018). PMID: 30106219.
  53. Honors and Awards:
    • Wiley Top Cited Paper Award (2020).
    Cover Article:
    • The Cover Article of CNS Neurosci Ther 2018 24(12), Download the Cover .

  54. W. Q. Xia, L. Y. Zheng, J. B. Fang, F. C. Li, Y. Zhou, Z. Y. Zeng, B. Zhang, Z. R. Li, H. L. Li*, F. Zhu*. PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods. Computers in Biology and Medicine (impact factor of the publication year: 6.698, 工程技术二区期刊). 145: 105465 (2022). PMID: 35366467
  55. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.40% in 2023.

  56. S. Zhang, K. Amahong, Y. T. Zhang, X. P. Hu, S. J. Huang, M. K. Lu, Z. Y. Zeng, Z. R. Li, B. Zhang, Y. Q. Qiu, H. B. Dai, J. Q. Gao, F. Zhu*. RNAenrich: a web server for non-coding RNA enrichment. Bioinformatics (impact factor of the publication year: 6.931, 生物二区 TOP 期刊). 39(7): btad421 (2023). PMID: 37399102.
  57. C. F. Xu, J. T. Huang, Y. Q. Gao, W. X. Zhao, Y. Q. Shen, F. H. Luo, G. Yu, F. Zhu*, Y. Ni*. OBMeta: a comprehensive web server to analyze and validate gut microbial features and biomarkers for obesity-associated metabolic diseases. Bioinformatics (impact factor of the publication year: 6.931, 生物二区 TOP 期刊). accepted: BIOINF-2023-1043 (2023). PMID: XXXXXXXX.
  58. M. J. Mou, Z. Q. Pan, M. K. Lu, H. C. Sun, Y. X. Wang, Y. C. Luo, F. Zhu*. Application of machine learning in spatial proteomics. Journal of Chemical Information and Modeling (impact factor of the publication year: 6.162, 化学二区期刊). 62(23): 5875–5895 (2022). PMID: 36378082
  59. Cover Article:
    • The Cover Article of J Chem Inf Model 2022 62(23), Download the Cover .

  60. T. T. Fu, G. Tu, M. Ping, G. X. Zheng, F. Y. Yang, J. Y. Yang, Y. Zhang, X. J. Yao, W. W. Xue*, F. Zhu*. Subtype selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacologica Sinica (impact factor of the publication year: 6.150, 医学一区 TOP 期刊). 42(8): 1354-1367 (2021). PMID: 33122823.
  61. J. Tang, J. B. Fu, Y. X. Wang, Y. C. Luo, Q. X. Yang, B. Li, G. Tu, J. J. Hong, X. J. Cui, Y. Z. Chen, L. X. Yao, W. W. Xue, F. Zhu*. Simultaneous improvement in the precision, accuracy and robustness of label-free proteome quantification by optimizing data manipulation chains. Molecular & Cellular Proteomics (impact factor of the publication year: 7.381, 生物一区 TOP 期刊). 18(8): 1683-1699 (2019). PMID: 31097671.
  62. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.87% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.81% in 2021.
    • The Percentile in Subject Area shown in InCites™ was 0.57% in 2020.

  63. F. C. Li, Y. Zhou, X. Y. Zhang, J. Tang, Q. X. Yang, Y. Zhang, Y. C. Luo, J. Hu*, W. W. Xue, Y. Q. Qiu, Q. J. He, B. Yang, F. Zhu*. SSizer: determining the sample sufficiency for comparative biological study. Journal of Molecular Biology (impact factor of the publication year: 5.067, 生物二区 TOP 期刊). 432(11): 3411-3421 (2020). PMID: 32044343.
  64. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 2.93% in 2023.

  65. Y. Zhang, J. B. Ying, J. J. Hong, F. C. Li, T. T. Fu, F. Y. Yang, G. X. Zheng, X. J. Yao, Y. Lou, Y. Q. Qiu, W. W. Xue*, F. Zhu*. How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from Trichostatin A enantiomers based on molecular dynamics. ACS Chemical Neuroscience (impact factor of the publication year: 4.211, 化学二区 TOP 期刊). 10(5): 2467-2480 (2019). PMID: 30784262.
  66. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.48% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 1.85% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 1.19% in 2021.
    • The Percentile in Subject Area shown in InCites™ was 0.74% in 2020.
    Cover Article:
    • The Cover Article of ACS Chem Neurosci 2019 10(5), Download the Cover .

  67. W. W. Xue, F. Y. Yang, P. P. Wang, G. X. Zheng, Y. Z. Chen, X. J. Yao, F. Zhu*. What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation. ACS Chemical Neuroscience (impact factor of the publication year: 4.211, 化学二区 TOP 期刊). 9(5): 1128-1140 (2018). PMID: 29300091.
  68. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.11% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.18% in 2022.
    • The Percentile in Subject Area shown in InCites™ was 0.14% in 2021.
    • The Percentile in Subject Area shown in InCites™ was 0.21% in 2020.
    • The Percentile in Subject Area shown in InCites™ was 0.29% in 2019.

  69. W. W. Xue, T. T. Fu, S. Z. Deng, F. Y. Yang, J. Y. Yang, F. Zhu*. Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram. ACS Chemical Neuroscience (impact factor of the publication year: 5.780, 医学二区期刊). 13(3): 340-351 (2022). PMID: 35041375.
  70. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.05% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 0.09% in 2022.

  71. F. Y. Yang, G. X. Zheng, T. T. Fu, X. F. Li, G. Tu, Y. H. Li, X. J. Yao, W. W. Xue*, F. Zhu*. Prediction of binding mode and resistance profile for dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase associated ribonuclease H. Physical Chemistry Chemical Physics (impact factor of the publication year: 4.123, 化学二区 TOP 期刊). 20(37): 23873-23884 (2018). PMID: 29947629.
  72. Back Cover Article:

  73. Q. X. Yang, B. Li, S. J. Chen, J. Tang, Y. H. Li, Y. Li, S. Zhang, C. Shi, Y. Zhang, M. J. Mou, W. W. Xue*, F. Zhu*. MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis. Journal of Proteomics (impact factor of the publication year: 4.044, 生物二区期刊). 232: 104023 (2021). PMID: 33130111.
  74. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.69% in 2023.
    • The Percentile in Subject Area shown in InCites™ was 2.51% in 2022.

  Licensed Patents and Copyrights
  1. F. Zhu, X. N. Sun, S. Zhang, M. J. Mou, et al. Software Copyright 2023SR0736962 approved by the National NCAC of China.
    A Software Tool for Metabolite and Protein Regulatory Network Analysis (2023)
  2. F. Zhu, M. J. Mou, X. N. Sun, C. Y. Zhang. Software Copyright 2023SR0682069 approved by the National NCAC of China.
    A Software Tool for Analyzing Biological Activities of Drug Inactive Ingredients (2023)
  3. F. Zhu, X. N. Sun, Y. T. Zhang, H. Y. Li, Y. Zhou. Software Copyright 2023SR0682068 approved by the National NCAC of China.
    A Software Tool for Comprehensive Drug Resistance Analysis (2023)
  4. F. Zhu, F. C. Li, H. C. Sun, J. Y. Yin. Software Copyright 2022SR1374536 approved by the National NCAC of China.
    A Software Tool for Metabolomics-based Quantitative Analysis of Large-scale and Long-term Microbiota Study (2022)
  5. F. Zhu, J. Y. Yin, F. C. Li, Y. Zhou, M. J. Mou. Software Copyright 2022SR1374538 approved by the National NCAC of China.
    A Software Tool for Interaction Analysis of Drug-metabolizing Enzyme Intergroup (2022)
  6. F. Zhu, F. C. Li, J. Y. Yin, M. K. Lu, M. J. Mou. Software Copyright 2022SR1374548 approved by the National NCAC of China.
    A Software Tool for Molecular Profiling of Drug Interactions (2022)
  7. F. Zhu, F. C. Li, J. Y. Yin, M. K. Lu, Q. X. Yang. Software Copyright 2022SR1374537 approved by the National NCAC of China.
    A Software Tool for Stable Identification of Molecular Features based on OMICS Data (2022)
  8. F. Zhu, F. C. Li, J. Y. Yin, Y. Zhou, Y. Zhang. Software Copyright 2022SR1374547 approved by the National NCAC of China.
    A Software Tool for High Precision Identification of Biomarkers Based on Proteomics Technology (2022)
  9. F. Zhu, M. J. Mou, J. Tang, X. N. Sun. Software Copyright 2022SR1096571 approved by the National NCAC of China.
    A Software Tool for Analyzing Host Regulatory Factors of Human Microbiota (2022)
  10. F. Zhu, M. J. Mou, J. Tang, Y. X. Wang, et al. Software Copyright 2021SR0027303 approved by the National NCAC of China.
    A Software Tool for Selecting Metaproteomic Features Based on Performance Assessment (2021)
  11. F. Zhu, J. Y. Yin, F. C. Li, X. X. Li, et al. Software Copyright 2021SR0822567 approved by the National NCAC of China.
    A Software Tool for Constructing Phylogenetic Tree Describing the Homology among Drug Transporters (2021)
  12. F. Zhu, F. C. Li, Y. Zhou, X. Y. Zhang. Software Copyright 2021SR0826823 approved by the National NCAC of China.
    A Software Tool for Determining Sample Sufficiency for Comparative Biological Study (2021)
  13. F. Zhu, S. Zeng, J. Y. Yin, F. C. Li. Software Copyright 2020SR0275172 approved by the National NCAC of China.
    A Software Tool for Analyzing the Interplay among the Variabilities of Drug Transporters (2020)
  14. F. Zhu, Y. X. Wang, Y. Z. Chen, S. Zhang, et al. Software Copyright 2020SR0526446 approved by the National NCAC of China.
    A Software Tool for Integrating the Epigenetics with the Protein-Protein Interactions of Drug Target (2020)
  15. F. Zhu, Y. X. Wang, S. Zhang, F. C. Li, et al. Software Copyright 2020SR0527384 approved by the National NCAC of China.
    A Software Tool for Strictly Validating the Primary Drug Target and Conducting Network Analysis (2020)
  16. F. Zhu, Y. X. Wang, S. Zhang, F. C. Li, et al. Software Copyright 2020SR0528155 approved by the National NCAC of China.
    A Software Tool for Strictly Identifying the Primary Therapeutic Target of the Drugs in Clinical Trial (2020)
  17. F. Zhu, J. J. Hong, J. Hu, L. Tao. Software Copyright 2020SR0274064 approved by the National NCAC of China.
    A Software Tool for Discovering the Bacterial Type-IV Secreting System Effector Protein (2019)
  18. F. Zhu, J. Tang, J. B. Fu, Y. X. Wang. Software Copyright 2020SR0274135 approved by the National NCAC of China.
    A Software Tool for Assessing Label-free Proteome Quantification from Multiple Perspectives (2019)
  19. F. Zhu, F. C. Li, S. Zhang, Y. X. Wang, et al. Software Copyright 2020SR0525443 approved by the National NCAC of China.
    A Software Tool for Discovering the Novel Drug Scaffold Based on Biomarker Identification (2019)
  20. F. Zhu, F. C. Li, S. Zhang, Y. X. Wang, et al. Software Copyright 2020SR0528147 approved by the National NCAC of China.
    A Software Tool for Identifying the Tissue-Specific Distribution Pattern of Therapeutic Target (2018)
  21. F. Zhu, Q. X. Yang, B. Li, Y. X. Wang. Software Copyright 2020SR0275177 approved by the National NCAC of China.
    A Software Tool for Evaluating Mass-spectrometry-based Metabolomic Data from Multiple Perspectives (2017)
  22. F. Zhu, S. Zhang, F. C. Li, Y. X. Wang, et al. Software Copyright 2020SR0528618 approved by the National NCAC of China.
    A Software Tool for Associating the Disease-Relevant Signaling Pathway with Therapeutic Target (2016)
  Hosted Conference and Symposium
  Invited Speaker of International/Domestic Conference
  Reviewer of Esteemed Journals (12 Representative Journals)
Nucleic Acids Res (IF = 19.160); Med Res Rev (IF = 12.944); Br J Pharmacol (IF = 8.739);
Nat Protoc (IF = 17.021); Brief Bioinform (IF = 13.994); Bioinformatics (IF = 6.931);
Proc Natl Acad Sci U S A (IF = 12.779); Anal Chem (IF = 8.008); Mol Pharmaceut (IF = 5.364);
J Med Chem (IF = 8.039); Pharmacol Res (IF = 10.334); J Chem Inf Model (IF = 6.162)


CURRENT GROUP MEMBERS
PROFESSOR AND LECTURER
Wei-Wei XUE
Cheminformatics

2014.06-now

Personal Homepage Email

2016.09-Now: Assoc. Professor in School of Pharmaceutical Sciences, CQU

2014.06-2016.09: Lecturer in Innovative Drug Research Centre, CQU

2009.09-2014.06: Master, Doctor in Department of Chemistry, LZU

2005.09-2009.06: Bachelor in Department of Chemistry, LZU

POSTDOCTORAL FELLOW
Yi-chao GE
Marine Science and Engineering

2023.07-now

Personal Homepage Email

2023.07-Now: Postdoctoral Fellow in College of Pharmaceutical Science, ZJU

2018.09-2023.03: Doctor in Ocean College, ZJU

2015.09-2018.03: Master, Doctor in School of Food Science and Biotechnology, ZJGSU

2011.09-2015.06: Bachelor in College of Biological & Environmental Sciences, ZJWU

Ting-Ting FU
Medicinal Chemistry

2023.09-now

Personal Homepage Email

2023.09-Now: Postdoctoral Fellow in College of Pharmaceutical Science, ZJU

2019.09-2023.09: Doctor in Institute of Theoretical Chemistry, JLU

2016.09-2019.06: Master, Doctor in School of Pharmaceutical Science, CQU

2012.09-2016.06: Bachelor in College of Veterinary Medicine, SAU

DOCTORAL CANDIDATE

Yong-Chao Luo
Pharmacy

2018.07-now
Home Email

Ting-Ting Fu
Medicinal Chemistry

2019.09-now
Home Email

Ying Zhou
Pharmacy

2019.01-now
Home Email

Ying Zhang
Pharmacy

2019.01-now
Home Email

Min-Jie Mou
Pharmacy

2019.05-now
Home Email

Yin-Tao Zhang
Pharmacy

2019.09-now
Home Email

GRADUATE STUDENT

Jing-Yi Yang
Medicinal Chemistry

2018.09-now
Home Email

Zhao Zhang
Medicinal Chemistry

2019.09-now
Home Email

Xiu-Na Sun
Pharmacy

2020.09-now
Home Email

Xi-Chen Lian
Pharmacy

2020.09-now
Home Email

Kuerbannisha Amahong
Pharmacy

2020.09-now
Home Email

Han-Yu Zhang
Pharmacy

2020.09-now
Home Email

Xiao-Na Wang
Pharmacy

2020.09-now
Home Email

Bin-Bin Xu
Pharmacy

2020.09-now
Home Email

Ling-Yan Zheng
Pharmacy

2020.09-now
Home Email

Huai-Cheng Sun
Pharmacy

2021.03-now
Home Email

Ming-Kun Lu
Pharmacy

2021.03-now
Home Email

Shui-Yang Shi
Pharmacy

2021.03-now
Home Email

Wei Zhang
Pharmacy

2021.03-now
Home Email

Han-Yang Li
Pharmacy

2021.03-now
Home Email

Zi-Qi Pan
Pharmacy

2022.09-now
Home Email

Zhen Chen
Pharmacy

2022.09-now
Home Email

Teng Li
Pharmacy

2022.09-now
Home Email

Nan-Xin You
Pharmacy

2022.09-now
Home Email

Shi-Jie Huang
Pharmacy

2022.09-now
Home Email

Zhi-Meng Zhou
Pharmacy

2023.09-now
Home Email

Xin-Yuan Yu
Pharmacy

2023.09-now
Home Email

Yuan Zhou
Pharmacy

2023.09-now
Home Email

Zhi-Chao Zhang
Pharmacy

2023.09-now
Home Email

Yang Liao
Pharmacy

2023.09-now
Home Email

CHINESE NATIONAL UNDERGRADUATE INNOVATIVE TEST PROGRAM AND STUDENT RESEARCH TRAINING PROGRAM

Kang-Li Chen
Pharmacy

2020.03-now
Home Email

Han-Xiang Xu
Pharmacy

2020.03-now
Home Email

Han-Qi Zheng
Pharmacy

2020.03-now
Home Email

IDRB: Innovative Drug Research and Bioinformatics Group


All rights are reserved by: Innovative Drug Research and Bioinformatics Group (IDRB)
College of Pharmaceutical Sciences, Zhejiang University
Hangzhou, P.R. China, 310058.
Contact number: (86 - 571)88208444
ICP ID: 浙ICP备18036997号-1

Last Update: